Traders rush for the exits in response to the company's fiscal-fourth-quarter earnings report and to an announced delay in two of its ongoing clinical studies.
News & Analysis: Applied Genetic Technologies
Multiple programs are in development.
Shares of Applied Genetic Technologies Corporation bolted higher today. Here's why.
Are these three stocks sells or belles? You be the judge!